2023
Targeting Redundant ROBO1 and SDF-1 Pathways Prevents Adult Hemangioblast Derived-EPC and CEC Activity Effectively Blocking Tumor Neovascularization.
Stem cell reviews and reports
•Christopher R. Cogle, M.D. is a physician and scientist with research focus on cancer and health policy. In his early career Dr. Cogle discovered that blood stem cells make blood vessels and used that biology to invent new therapeutics and diagnostics for people with cancer and heart disease. In his mid career, as a Leukemia & Lymphoma Society Scholar in Clinical Research, he translated laboratory research discoveries into investigator-initiated clinical trials. Dr. Cogle has also made major discoveries in cancer epidemiology and was elected to lead Florida’s cancer prevention and control efforts at the state level, producing the Florida Cancer Plan, leading statewide campaigns for improved cancer prevention and control, and advising the Florida Legislature, Florida Secretary of ÍøºìºÚÁÏ, and Florida Governor on evidence-based strategies to reduce the state's cancer burden. In 2020, Dr. Cogle was selected by the National Academy of Medicine as an Emerging Leader in ÍøºìºÚÁÏ and Medicine Scholar. In 2021, Dr.Cogle founded the Florida ÍøºìºÚÁÏ Policy Leadership Academy at the Bob Graham Center for Public Service. His academy team of faculty trains Florida's community leaders in promoting health and preventing disease and disease progression for Florida's 21 million residents and 100 million visitors. In 2023, he was selected by the Milbank Memorial Foundation as a state health policy fellow.
172 publications
2023
Stem cell reviews and reports
•2023
Transplantation and cellular therapy
•2022
Clinical cancer research : an official journal of the American Association for Cancer Research
•2022
Molecular cell
•2022
ÍøºìºÚÁÏcare
•